Effectiveness Evaluation for Production Drugs Crystal Groesbeck, Ph.D Division of Production Drugs.

Slides:



Advertisements
Similar presentations
Office of New Animal Drug Evaluation Laura L. Hungerford, DVM, MPH, PhD Senior Advisor, Science and Policy, ONADE Professor, University of Maryland School.
Advertisements

III. Drug Metabolism  The aim of drug metabolism is to convert lipid soluble (non polar) drugs to polar metabolites easily excreted in urine.  The liver.
Public Health Issues Related to Mutually Conforming Labeling: CDRH Perspective Miriam C. Provost, Ph.D. Office of Device Evaluation Center for Devices.
Pork Checkoff National Pork Board.  Food Safety  Animal Well-Being.
Drug Utilization Review (DUR)
University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Romania Since 1869 Anti-microbial resistance – Urgent need to act in human and.
What Do Toxicologists Do?
Animal Production Basics to Being Successful. What’s The Purpose? What are you producing your animals for? –Example: Sheep –Wool –Meat Cattle –Dairy –Meat.
Lesson 10 Good Production Practice #10 Provide proper swine care to improve swine well-being.
Monogastric Nutrition Nutrient Requirements Simple Stomached –Require readily digestible feed –Cannot use complex carbohydrates Cellulose, hemicellulose,
Effectiveness Evaluation for Therapeutic Drugs for Non-Food Animals
Principles of New Animal Drug Effectiveness: An Overview
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
Mrs. Brandi Robinson Office of New Animal Drug Evaluation Center for Veterinary Medicine Regulating Animal Drugs.
Codex Guidelines for the Application of HACCP
Drug and Product Labeling
Purpose of projects There are 3 major purposes of students getting involved with project programs: Character Development Knowledge of the livestock industry.
Christian Asher.  there are more than 50,000 Dietary supplements available on the market today.  Dietary supplements are more popular than they’ve ever.
Great Plains Veterinary Educational Center A Little On Drug Use Antibiotic Use GuidelinesAMDUCA (Animal Medicinal Drug Use Clarification Act)ELDU (Extra.
West Virginia University Laboratory Training Module 1. OSHA Laboratory Standard.
Environmental Resources Unit C Animal Wildlife Management.
Overview of the Clinical Trial & Protocol Jane Fendl March 31, 2010
CVM’s Procedure for Setting Tolerances
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
D. H. “Denny” Crews, Jr. Colorado State University BIF SubCommittee Chair.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,
Medication/ Medication Administration
When do I need an IND ? FDA Guidance for Industry – Investigation New Drug Applications (INDs) - Determining Whether Human Research Studies Can Be Conducted.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Nonclinical Perspective on Initiating Phase 1 Studies for Small Molecular Weight Compounds John K. Leighton, PH.D., DABT Supervisory Pharmacologist Division.
CHEE DRUG PRODUCT DEVELOPMENT u Drug ä agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in man or animals.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
Dietary Supplements. Definition by DSHEA Product that is to supplement a healthy diet. Includes ingredients such as vitamins, minerals, herbs, botanicals,
ENVIRONMENT & ANIMAL HEALTH by David R. Hawkins Michigan State University.
CTD, Safety Tanja Braakman Genzyme Europe BV Pharmacovigilance Department.
 1. A care plan is developed for each of the patient's medical conditions being managed with pharmacotherapy.  2. A goal of therapy is the desired response.
Reading Medication Labels Small Animal Management 130.4(c)2D.
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
Good Production Practice #6 Assuring Quality Care for Animals
OHIO STATE UNIVERSITY EXTENSION Follow Proper Feed Processing Protocols Good Production Practice #5 Assuring Quality Care for Animals Food Animal Quality.
How To Design a Clinical Trial
Population Numbers AG-WL-6. Population Dynamics  Short and long term changes in the size and age composition of populations, and the biological and environmental.
What is Metabolism? Metabolism is: How the Body uses Food Turning fats and carbs into energy Turning protein into muscle and tissue repair.
Introduction to the Child health Nursing and Nutritional Need Lecture 1 1.
Suzanne Sechen, Ph.D. Leader, Ruminant Drugs Team Division of Production Drugs Office of New Animal Drug Evaluation, CVM Labeling Issues.
Swine Show Success A guide for management of show pigs Including the use of Paylean ® in show pigs.
Awareness Training: ‘HARPC’ for Food Safety Complimentary Presentation by Quality Systems Enhancement 1790 Wood Stock Road Roswell GA E. mail:
Feed Additives and Hormones Animal Science II Objective
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 9 CH 8 ISO MEASUREMENT, ANALYSIS AND IMPROVEMENT INTERNAL AUDITS.
OVER THE COUNTER MEDS INTRODUCTION No prescriptions are necessary and no questions need to be answered to attain these drugs OTC med use saves.
Responsible Use of Livestock Drugs Dave Sparks D.V.M Area Extension Food Animal Quality and Health Specialist.
Given the progress that continues to be made in society’s battle against disease, patients are seeking more information about medical problems and potential.
Prevention and Treatment Ms. Edmonson. Objectives Identify management practices to prevent disease. Identify various treatment methods.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.
Clinical Trials.
Medical Necessity Criteria An Overview of Key Components Presented by BHM Healthcare Solutions.
CLINICAL TRIALS.
Veterinary Feed Directive
Follow Proper Feed Processing Protocols
Controlled drug release
Pharmacovigilance in clinical trials
Assuring Quality Care for Animals Youth Food Animal Quality Assurance
The Nursing Process and Pharmacology Jeanelle F. Jimenez RN, BSN, CCRN
Chapter 4: Food Hazard Analysis
Speeding access to therapies
Opening an IND: Investigator Perspective
Principles and Methods of Drug Administration
Nutrition & Fitness Lecture 8 – Part 1.
Use an Appropriate Veterinarian/Client/Patient Relationship (VCPR) as the Basis for Medication Decision-Making Good Production Practice #1 Assuring Quality.
Presentation transcript:

Effectiveness Evaluation for Production Drugs Crystal Groesbeck, Ph.D Division of Production Drugs

Articles, other than food, intended to affect the structure or function of the body of an animal Administered to enhance the production of edible or non-edible products, or to increase the efficiency of a particular phase of life, including reproduction Different from therapeutic animal drugs which are intended to diagnose, cure, mitigate, treat, or prevent disease in animals What are Animal Production Drugs?

Common Indications for Animal Production Drugs Increased rate of weight gain Improved feed efficiency Synchronization of estrus Increased production of marketable milk Carcass characteristics (e.g. carcass leanness)

Purpose  To evaluate the indications proposed for the new animal production drug under expected conditions of use  Can also provide information for product labeling that is helpful to the user of the drug Field Effectiveness Studies for Animal Production Drugs

The large number of animals often used in effectiveness studies provides the opportunity for the detection of low frequency adverse events Therefore, the effectiveness study may also provide information on the potential adverse effects of a new animal production drug on animal product quality, such as meat quality or milk composition Field Effectiveness Studies for Animal Production Drugs

Dosage and Dose Selection The intended dosage of the new animal production drug should be determined, including the chosen drug concentration, dose, route of administration, frequency of treatment, and the duration of treatment A dose or dose range is approvable up to a maximum dose that is effective and does not cause human or target animal safety concerns

A protocol can be developed and used as a guide so that all sites perform their studies similarly Study Design

Sufficient numbers of animals should be included in the treatment groups to accommodate loss during the study due to death or removal from the study When pen, pasture, or cage is the experimental unit, the number of animals per pen, pasture, or cage should mimic common commercial practices for stocking density, taking research facility limitations into account Number of Animals

Effectiveness studies for new animal production drugs should use normal, healthy animals that are representative of their class Other selection criteria such as age or weight range, gender, previous milk production, and previous exposure to production drugs should be clearly identified and defined Animal Selection Criteria

For indications associated with meat production, treatment usually will be conducted until animals reach a terminal weight (slaughter or market) For reproductive indications, the study length should be sufficient to evaluate effectiveness and reproductive target animal safety For dairy production indications, the length of the study will generally be long enough to evaluate drug effects on the “production lifespan” of the animal Length of Study

Water and feed should be provided to study animals for ad libitum consumption or in accordance with current industry practices for the species/class Rations should be formulated to meet or exceed the animals’ nutrient requirements and reflect current industry practice The particle size, texture, form of the feed, and the feeding routine should be similar across all treatment groups Feeding and Nutrition

If necessary, feeds should be assayed for nutrient composition at intervals appropriate for the species, class, and production phase to ensure that the ration meets nutrient requirements Feeds or feed ingredients should be assayed for anti- quality factors (e.g. mycotoxins, gossypol), as appropriate, for each feed ingredient and/or the environmental conditions under which it was raised and stored Feeding and Nutrition

If the production drug is delivered via medicated feed, the Type B (intermediate mix) and Type C feeds (what is fed to the animal) should be assayed for drug concentration at appropriate intervals For indications involving production efficiency (efficiency of weight gain or milk production efficiency), feed intake should be accurately measure and are obtained per experimental unit Feeding and Nutrition

At a minimum, record all feed offered during the study and all feed remaining in feeders at the end of the study If the indication is to extend over several production phases, feed intake should be collected for each phase Feeding and Nutrition

All study animals should be observed at planned periodic intervals appropriate for the management and experimental conditions All abnormal signs should be recorded, such as reduced feed intake, lameness, abnormal respiration, and discharges Health Observations

Animals may be treated with appropriate doses of therapeutic drugs for all their labeled indications. Acceptable concomitant therapies should be incorporated into the protocol before initiating the study Health Observations

Animal Removals Once animals begin treatment they should only be removed from the study due to illness or injury that, in the opinion of a qualified veterinarian, will interfere with their ability to function normally or for humane reasons Animals removed from the study after the initiation of treatment should not be replaced Animals should not be removed from the study simply because of poor performance

Animal Removals Death or removal of animals from the study due to an illness or injury should be recorded along with the reason for removal Necropsies should be performed on all animals that die or are euthanized to determine the cause of the mortality or morbidity, respectively

For Additional Information: “Principles of New Animal Drug Effectiveness: An Overview” “Effectiveness Evaluations for Therapeutic Drugs for Food Animals” “Effectiveness Evaluations for Therapeutic Drugs for Non-Food Animals”